Referred to the House Committee on Energy and Commerce.
The bill exempts surplus broiler hatching eggs sold to commercial egg breakers from application of 21 CFR 118.4(e) beginning at enactment.
It directs HHS/FDA, in consultation with USDA, to revise 21 CFR 118.4 within 180 days to permit holding temperatures and times compatible with hatching so those surplus eggs may be sold to egg breakers and processed under the Egg Products Inspection Act.
The bill defines key terms: egg, egg product, egg breaker, broiler hatching egg, and broiler hatchery.
Limited scope and low fiscal impact help chances, but food-safety scrutiny and need for Senate accommodation reduce overall likelihood.
Relative to its intended legislative type, this bill is a focused statutory instruction to alter the applicability of an existing regulatory provision and to require a conforming FDA rule within a short timeframe. It clearly identifies the regulation to be affected, responsible agencies, and relevant definitions, but it delegates substantive technical specifics and safety/operational controls to the forthcoming rule without providing fiscal, transitional, or accountability provisions in the statute itself.
Safety vs. deregulatory flexibility: public-health risk concerns versus cost savings
Safety vs. deregulatory flexibility: public-health risk concerns versus cost savings
Likely cautiously mixed.
Supporters would welcome reducing food waste and lowering consumer prices, but many would worry about any deregulatory step that could weaken food-safety protections.
They would want strong, enforceable safeguards and monitoring in the revised regulation.
Pragmatic but cautious.
Sees value in reducing waste and lowering costs for downstream processors if food safety is preserved.
Wants evidence-based rulemaking, clear timelines, and measurable safety standards in the 180-day revision.
Generally supportive.
Frames the bill as sensible deregulation that reduces waste, lowers costs, and provides flexibility to industry.
Views the 180-day revision and consultation with USDA as adequate oversight while removing an unnecessary restriction.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Limited scope and low fiscal impact help chances, but food-safety scrutiny and need for Senate accommodation reduce overall likelihood.
The bill has not accumulated any surfaced votes yet.
Safety vs. deregulatory flexibility: public-health risk concerns versus cost savings
Limited scope and low fiscal impact help chances, but food-safety scrutiny and need for Senate accommodation reduce overall likelihood.
Relative to its intended legislative type, this bill is a focused statutory instruction to alter the applicability of an existing regulatory provision and to require a conforming FDA rule within a short timeframe. It cl…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.